Other cell cycle regulators, such as the DNA damage checkpoint kinases and spindle-assembly checkpoint proteins, are also being evaluated as potential new drug targets to improve cancer therapy.

Cyclin–CDK complexes are the ultimate targets of several cell-cycle checkpoints that ensure the maintenance of genomic integrity and cellular good health 13, 14.